View of How the CRISPR-Cas9 Gene Editing Complex Can Be Used to Treat Human Immunodeficiency Virus 1 and Sickle Cell Disease with Immune Cell Therapies and Genetic Engineering with Insight Into its Societal Impacts

Return to Article Details How the CRISPR-Cas9 Gene Editing Complex Can Be Used to Treat Human Immunodeficiency Virus 1 and Sickle Cell Disease with Immune Cell Therapies and Genetic Engineering with Insight Into its Societal Impacts Download Download PDF